Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP626127.RAaKgD8nG7F3XEUoc3rdOjvq-tQRmW30dMN0nFY0yCK-s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP626127.RAaKgD8nG7F3XEUoc3rdOjvq-tQRmW30dMN0nFY0yCK-s130_assertion type Assertion NP626127.RAaKgD8nG7F3XEUoc3rdOjvq-tQRmW30dMN0nFY0yCK-s130_head.
- NP626127.RAaKgD8nG7F3XEUoc3rdOjvq-tQRmW30dMN0nFY0yCK-s130_assertion description "[Therefore, it is highly expected that, by measuring the expression levels of SAT-I mRNA in lung biopsy samples from non-small cell lung cancer patients, enhanced pathological identification and individualized chemotherapeutic strategies can be established for the appropriate use of EGFR-TK inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP626127.RAaKgD8nG7F3XEUoc3rdOjvq-tQRmW30dMN0nFY0yCK-s130_provenance.
- NP626127.RAaKgD8nG7F3XEUoc3rdOjvq-tQRmW30dMN0nFY0yCK-s130_assertion evidence source_evidence_literature NP626127.RAaKgD8nG7F3XEUoc3rdOjvq-tQRmW30dMN0nFY0yCK-s130_provenance.
- NP626127.RAaKgD8nG7F3XEUoc3rdOjvq-tQRmW30dMN0nFY0yCK-s130_assertion SIO_000772 17711504 NP626127.RAaKgD8nG7F3XEUoc3rdOjvq-tQRmW30dMN0nFY0yCK-s130_provenance.
- NP626127.RAaKgD8nG7F3XEUoc3rdOjvq-tQRmW30dMN0nFY0yCK-s130_assertion wasDerivedFrom befree-2016 NP626127.RAaKgD8nG7F3XEUoc3rdOjvq-tQRmW30dMN0nFY0yCK-s130_provenance.
- NP626127.RAaKgD8nG7F3XEUoc3rdOjvq-tQRmW30dMN0nFY0yCK-s130_assertion wasGeneratedBy ECO_0000203 NP626127.RAaKgD8nG7F3XEUoc3rdOjvq-tQRmW30dMN0nFY0yCK-s130_provenance.